Research Paper Volume 15, Issue 23 pp 14141—14171
Comprehensive analysis reveals key genes and environmental toxin exposures underlying treatment response in ulcerative colitis based on in-silico analysis and Mendelian randomization
Figure 5. (A) The Venn diagram displays immune cells with differential infiltration between high and low levels of ELL2 expression across all treated cohorts. The differences in infiltration of B cells and iTregs between patients with high and low levels of ELL2 in UC cohorts treated with 5-ASA (B), corticosteroid (C), golimumab (D), and infliximab (E).